658 related articles for article (PubMed ID: 32284036)
1. Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019).
El-Sayed Ahmed MAE; Zhong LL; Shen C; Yang Y; Doi Y; Tian GB
Emerg Microbes Infect; 2020 Dec; 9(1):868-885. PubMed ID: 32284036
[TBL] [Abstract][Full Text] [Related]
2. Colistin, mechanisms and prevalence of resistance.
Bialvaei AZ; Samadi Kafil H
Curr Med Res Opin; 2015 Apr; 31(4):707-21. PubMed ID: 25697677
[TBL] [Abstract][Full Text] [Related]
3. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
Ardebili A; Izanloo A; Rastegar M
Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
[TBL] [Abstract][Full Text] [Related]
4. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant Gram-negative infections: what are the treatment options?
Giamarellou H; Poulakou G
Drugs; 2009 Oct; 69(14):1879-901. PubMed ID: 19747006
[TBL] [Abstract][Full Text] [Related]
6. Rational use of intravenous polymyxin B and colistin: A review.
Zakuan ZD; Suresh K
Med J Malaysia; 2018 Oct; 73(5):351-359. PubMed ID: 30350826
[TBL] [Abstract][Full Text] [Related]
7. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
Evans ME; Feola DJ; Rapp RP
Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.
Papadopoulos A; Ribera A; Mavrogenis AF; Rodriguez-Pardo D; Bonnet E; Salles MJ; Dolores Del Toro M; Nguyen S; Blanco-García A; Skaliczki G; Soriano A; Benito N; Petersdorf S; Pasticci MB; Tattevin P; Tufan ZK; Chan M; O'Connell N; Pantazis N; Kyprianou A; Pigrau C; Megaloikonomos PD; Senneville E; Ariza J; Papagelopoulos PJ; Giannitsioti E;
Int J Antimicrob Agents; 2019 Mar; 53(3):294-301. PubMed ID: 30395988
[TBL] [Abstract][Full Text] [Related]
11. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
[TBL] [Abstract][Full Text] [Related]
12. Clinical Use of Polymyxin B.
Rigatto MH; Falci DR; Zavascki AP
Adv Exp Med Biol; 2019; 1145():197-218. PubMed ID: 31364080
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of polymyxin resistance and detection of mcr genes.
Mlynarcik P; Kolar M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):28-38. PubMed ID: 30439931
[TBL] [Abstract][Full Text] [Related]
14. Polymyxin B: similarities to and differences from colistin (polymyxin E).
Kwa A; Kasiakou SK; Tam VH; Falagas ME
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
[TBL] [Abstract][Full Text] [Related]
15. MCR: modern colistin resistance.
Caniaux I; van Belkum A; Zambardi G; Poirel L; Gros MF
Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):415-420. PubMed ID: 27873028
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
17. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
[TBL] [Abstract][Full Text] [Related]
18. Polymyxins for CNS infections: Pharmacology and neurotoxicity.
Velkov T; Dai C; Ciccotosto GD; Cappai R; Hoyer D; Li J
Pharmacol Ther; 2018 Jan; 181():85-90. PubMed ID: 28750947
[TBL] [Abstract][Full Text] [Related]
19. Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?
Ozsurekci Y; Aykac K; Cengiz AB; Bayhan C; Sancak B; Karadag Oncel E; Kara A; Ceyhan M
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):233-8. PubMed ID: 27041107
[TBL] [Abstract][Full Text] [Related]
20. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
Huang J; Tang YQ; Sun JY
Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
